ShangHai JIAI Genetics&IVF Institute
Shanghai, China
NCT Number: NCT05739019
This is a prospective observational study. In this study, we aim to investigate the effect of a recent past Covid-19 infection on the live birth rate in the frozen embryo transfer cycles
Looking for future studies?
Notify Me20 year–42 year
Female
Observational
Shanghai, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
transfer one or two embryos in frozen embryo transfer cycles
Time frame: a live birth after 22 weeks gestation
live birth rate of the frozen embryo transfer cycle (>22 weeks of gestation)
Time frame: a blood pregnancy test is performed 14 days after the embryo transfer
serum hCG level
Time frame: presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy
presence of intrauterine gestational sac on ultrasound
Time frame: viable pregnancy beyond gestation 12 weeks
viable pregnancy beyond gestation 12 weeks
Time frame: positive blood pregnancy test not followed by clinical pregnancy during 12 weeks gestation
positive blood pregnancy test not followed by clinical pregnancy
Time frame: number of gestational sacs per embryo transferred during 4 weeks of pregnancy
number of gestational sacs per embryo transferred
Time frame: multiple pregnancy beyond gestation 12 weeks
more than one intrauterine sacs on scanning
Time frame: ectopic pregnancy during 12 weeks gestation
pregnancy outside the uterine cavity
Time frame: the loss of a pregnancy before 22 weeks gestation
the loss of a pregnancy before 22 weeks gestation
Time frame: a live birth after 22 weeks gestation
birth weight of the baby delivered
Time frame: 7 days before embryo transfer
serum COVID-19 antibody level immunoglobulin G and immunoglobulin M
ShangHai Ji Ai Genetics & IVF Institute
Other
A Prospective Observational Study of the Impact of a Recent Past COVID-19 Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07722000
COVID-19, Chronic Disease
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT04371432
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial Details